mitoguazone and Anemia

mitoguazone has been researched along with Anemia* in 1 studies

Other Studies

1 other study(ies) available for mitoguazone and Anemia

Article	Year
Phase II trial of mitoguazone in patients with advanced squamous cell carcinoma of the head and neck. Cancer treatment reports, 1983, Volume: 67, Issue:1 We used mitoguazone (500 mg/m2 iv weekly, with 50-mg/m2 escalations weekly as tolerated) to treat 22 patients with squamous cell carcinoma of the head and neck which recurred after initial therapy. Nine of 22 (11%) patients responded: two had complete responses and seven had partial responses. Gastrointestinal toxicity and anemia were commonly seen. We conclude that mitoguazone is active in squamous cell carcinoma of the head and neck and should be incorporated into phase III trials. Topics: Adult; Aged; Anemia; Carcinoma, Squamous Cell; Drug Evaluation; Gastrointestinal Diseases; Guanidines; Head and Neck Neoplasms; Humans; Middle Aged; Mitoguazone; Prognosis	1983

Article

Year

Phase II trial of mitoguazone in patients with advanced squamous cell carcinoma of the head and neck.

Cancer treatment reports, 1983, Volume: 67, Issue:1

We used mitoguazone (500 mg/m2 iv weekly, with 50-mg/m2 escalations weekly as tolerated) to treat 22 patients with squamous cell carcinoma of the head and neck which recurred after initial therapy. Nine of 22 (11%) patients responded: two had complete responses and seven had partial responses. Gastrointestinal toxicity and anemia were commonly seen. We conclude that mitoguazone is active in squamous cell carcinoma of the head and neck and should be incorporated into phase III trials.

Topics: Adult; Aged; Anemia; Carcinoma, Squamous Cell; Drug Evaluation; Gastrointestinal Diseases; Guanidines; Head and Neck Neoplasms; Humans; Middle Aged; Mitoguazone; Prognosis

1983